About this trial

The purpose of this study is to find out if Meaning-Centered Psychotherapy for Latinos (MCP-L) helps reduce anxiety and depression and improves quality of life compared to cognitive behavioral therapy (CBT). Investigators also want to learn what participants and providers think about the therapy, including how the therapy is designed, outside factors, available resources, and how the people involved affect how well MCP-L works.

Eligibility criteria

Qualifiers

Pathologically confirmed breast, prostate, colorectal, thyroid, cervix, uteri, or lung - solid tumor cancer (either most recent or new diagnosis)

Definition of Disease [or Measurable Disease]

Diagnosed with stages III or IV

Prior Treatment

Disqualifiers

Prior Treatment

Received psychological or psychiatric care at INCan in the last 3 months

In the judgment of the treating physician, protocol investigators, and/or study staff, presence of cognitive impairment (e.g., delirium or dementia) sufficient to preclude meaningful informed consent and/or study participation

Diagnosed with a serious psychiatric condition

Trial design

Treatments tested in this trial

  • Meaning-Centered Psychotherapy for Latinos /MCP-L

Treatment groups

300 Participants
are divided into 2 treatment groups

Locations

2
Mexico
Instituto Nacional de Cancerología (INCan) Mexico City Mexico
United States
Memorial Sloan Kettering Cancer Center10065, New YorkNew York, United States

Sponsors and collaborators

Memorial Sloan Kettering Cancer Center

Lead sponsor